Pharmspot
Your faithful ally when landing a new pharma market
Pharmspot covers critical pieces of info needed for a medicine market entry decision, including:drug approval, intellectual property, and exclusivities.
01 Reliability
Reliable drug patent linkage
Pharmspot includes drugs approved by the US-FDA and JP-PMDA and adds the patents linked to each drug as well as accurate expiry dates for every patent. The reliability of the linkage enables pharma companies, especially generics, to quickly understand if and when they could enter a new market.
02 Coverage
Core patent coverage
Pharmspot includes 9,200+ core patents and 200,000 family members, relevant to 25400+ drugs approved in the U.S. and Japan. The coverage of core drug patents allows users to more efficiently assess the legal risks associated with market entry and track legal status changes of out.
03 Edge
Purple Book patent data
Distinct from Orange Book (FDA-approved chemical rugs) which includes patents, Purple Book (FDA-approved biological drugs) is missing patent data. While regulations have been modified to require the submission of patents exchanged in "Patent Dance", the number of involved drugs and patents is limited. Pharmspot’s Purple Book patent data goes far beyond this, making it especially useful for companies looking to expand their product portfolio in the US market for biological/biosimilar drugs.
Our Offerings
Our flexible delivery methods allow you to maximize the value of the data.
SaaS platform
The subscription-based platform allows users to access critical patent and exclusivity data and insights about a drug through a simple query, enabling them to strategize and navigate the complex landscape of pharmaceutical intellectual property faster while reducing costs.
Bulk Data
The data set, consisting of backfiles and updates, can be easily integrated into any industry database that has certain drug data or patent data but not the type/quality of metadata we offer, thereby empowering the search & analytics capabilities of such a database.
Consulting
Through our consulting engagements, we provide customized solutions and expert insights to meet specific customer needs. The engagements may entail providing deeper analysis and interpretation of existing drug patents or conducting a thorough patent review and assessment.
Latest News
About Us
IPDataLab is a technology company focused on enhancing the accessibility and utility of patent information. Positioned at the intersection of patent data and software management, our mission is to link individual patents to indicators of corresponding commercial activity. As a separate entity from IPDataLab USA, IPDataLab Canada focuses on the pharmaceutical sector and is responsible for Pharmspot.
